Muscarinic antagonists with PARP and SiR modulating activity as cytoprotective agents

Details for Australian Patent Application No. 2005263577 (hide)

Owner ProteoSys AG

Inventors Schrattenholz, Andre

Agent Davies Collison Cave

Pub. Number AU-B-2005263577

PCT Pub. Number WO2006/008118

Priority 60/656,379 28.02.05 US; 60/620,323 21.10.04 US; 60/588,354 16.07.04 US; 60/656,378 28.02.05 US

Filing date 18 July 2005

Wipo publication date 26 January 2006

Acceptance publication date 22 April 2010

International Classifications

A61K 31/5513 (2006.01)

A61K 31/5517 (2006.01)

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61K 31/554 (2006.01) - having at least one nitrogen and at least one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

8 February 2007 PCT application entered the National Phase

  PCT publication WO2006/008118 Priority application(s): WO2006/008118

22 April 2010 Application Accepted

  Published as AU-B-2005263577

6 May 2010 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 13 Apr 2010. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000 2006

26 August 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 13 Apr 2010 2006

2 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005263578-Muscarinic antagonists with PARP and SIR modulating activity as agents for inflammatory diseases

2005263570-Selective insecticides based on substituted, cyclic keto-enols and safeners